≡Menu

Our Blog

Home/Blog

October 23, 2025

FCA Qui Tam, Whistleblowers

HHS Inspector General Exposes $11.5 Million Genetic Testing Fraud Scheme

On September 19, 2025, the Department of Justice (“DOJ”) announced that Robert Desselle, a healthcare marketer from Sarasota, FL, was convicted on charges of

October 22, 2025

FCA Qui Tam, Whistleblowers

The Evolution of Whistleblower Lawsuits in PPP Loan Fraud

Explore how whistleblower lawsuits evolved to expose Paycheck Protection Program (PPP) loan fraud, recover billions, and strengthen False Claims Act enforcement.

October 21, 2025

ERISA

Smoking Surcharges Under Fire: ERISA Compliance Risks in Wellness Programs

A recent ERISA case challenges employer tobacco-use surcharges, highlighting key compliance risks for wellness programs under ERISA, HIPAA, and the ADA.

October 20, 2025

Whistleblowers, FCA Qui Tam

Semler Scientific and Cipria Pay $37 Million to Resolve Medical Device Fraud Allegations

Semler Scientific Inc. (“Semler Scientific”) and Bard Peripheral Vascular Inc. (“Bard Inc.”) have agreed to pay nearly $37 million to settle allegations that

October 14, 2025

Whistleblowers, FCA Qui Tam

A $60 Billion Problem: Annual Medicare Losses Due to Fraud and Abuse

Medicare loses an estimated $60 billion annually to fraud, abuse & billing scams — learn how whistleblowers & the False Claims Act help expose and recover these losses.

October 13, 2025

Antitrust

Nvidia Antitrust Violation Finding in China Signals Rising Global Enforcement Risks

Nvidia faces an antitrust violation finding in China over its Mellanox merger, highlighting rising global enforcement and competition law risks. | Miller Shah LLP

October 06, 2025

Business and Corporate Services

Top M&A Deals of Q3 2025

Top M&A deals of Q3 2025 revealed: key mergers, acquisitions, and trends shaping energy, healthcare, and tech industries. Expert insight into deal value drivers.

October 03, 2025

Class Action

Volvo C40 Safety Issues Under Investigation: 2024-2025 Models Report Serious Defects

2024–2025 Volvo C40s are under investigation for serious safety defects, including display shutdowns while driving and sudden rear-brake activations, posing risks to drivers and passengers.

October 01, 2025

FCA Qui Tam

Illumina’s $9.8M Settlement Highlights Expanding Cybersecurity False Claims Act Enforcement

Illumina Inc. (“Illumina”) will pay $9.8 million to resolve allegations that it violated the False Claims Act (“FCA”) by selling DNA sequencing tools to

September 30, 2025

Employment, Wage and Hour

Bayada Nurse Wage Settlement Finalized at $13.5M With Miller Shah LLP as Co-Counsel

On August 25th, 2025, nine years after the case was filed, Pennsylvania Court of Common Pleas Judge Michael Erdos approved a $13.5 million BAYADA Home Health

While this website provides general information, it does not constitute legal advice. The best way to get guidance on your specific legal issue is to contact a lawyer. To schedule a meeting with an attorney, please call 866-540-5505 or complete the intake form to email us. To inquire about employment opportunities with Miller Shah LLP, please see our Opportunities page.

Offices Throughout
the United States & Italy

Get Fort Lauderdale Directions

Telephone

Attorney Advertising. This information is designed for general information only. The information presented should not be construed to be formal legal advice nor the formation of a lawyer/client relationship. Past results and testimonials are not a guarantee, warranty, or prediction of the outcome of your case, and should not be construed as such. Past results cannot guarantee future performance. Any result in a single case is not meant to create an expectation of similar results in future matters because each case involves many different factors, therefore, results will differ on a case-by-case basis. By providing contact information, users acknowledge and give explicit consent to be contacted via the methods of communication provided, including SMS. Message and data rates may apply. Message frequency may vary. Reply STOP to opt out.